Latest penny stock buys 10,000+
Purchases at a share price under $5.
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 | 2026-02-18 | SINT | Sintx Technologies, Inc. | Anderson Mark Lewis | Dir | P - Purchase | $3.02 | +3,000 | 18.0K | +20% | +$9,060 | |
| MI | 2026-02-19 | 2026-02-17+ | SNES | SenesTech, Inc. | GLENBROOK CAPITAL MANAGEMENT | 10% | P - Purchase | $2.33 | +85.9K | 669.6K | +15% | +$200.5K |
| MI | 2026-02-19 | 2026-02-11 | SLQT | SelectQuote, Inc. | Grant Robert Clay | Pres | P - Purchase | $0.8866 | +118.9K | 100.8K | New | +$105.4K |
| I | 2026-02-19 | 2026-02-17 | CMRC | Commerce.com, Inc. | Siminoff Ellen F | Executive COB, Dir | P - Purchase | $2.94 | +100.0K | 353.3K | +39% | +$294.0K |
| 2026-02-19 | 2026-02-19 | XFLT | XAI Floating Rate & Alternative Income Trust | Spence John Yogi | VP | P - Purchase | $3.90 | +5,000 | 561.8K | +0.9% | +$19.5K | |
| M | 2026-02-19 | 2026-02-17+ | BLIN | Bridgeline Digital, Inc. | Kahn Roger E. | Pres, CEO, Dir, 10% | P - Purchase | $0.7773 | +54.3K | 1.76M | +3% | +$42.2K |
| MI | 2026-02-19 | 2026-02-18 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.75 | +774 | 65.9K | +1% | +$2,128 |
| 2026-02-19 | 2026-02-18 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.75 | +360 | 148.8K | +0.2% | +$990 | |
| 2026-02-19 | 2026-02-18 | TSI | TCW STRATEGIC INCOME FUND INC | McMillan Peter | Dir | P - Purchase | $4.70 | +32.6K | 250.0K | +15% | +$153.3K | |
| 2026-02-18 | 2026-02-17 | GGT | GABELLI MULTIMEDIA TRUST INC. | BOGAN ELIZABETH C | Dir | P - Purchase | $4.05 | +2,700 | 2,700 | New | +$10.9K | |
| M | 2026-02-18 | 2026-02-18 | NTWK | NETSOL TECHNOLOGIES INC | GHAURI NAJEEB | CEO, Dir | P - Purchase | $3.25 | +6,000 | 934.0K | +0.6% | +$19.5K |
| MI | 2026-02-18 | 2025-09-04+ | VELO | Velo3D, Inc. | Lloyd Jason Michael | Dir | P - Purchase | $3.91 | +7,000 | 13.4K | +110% | +$27.4K |
| I | 2026-02-18 | 2026-02-18 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Executive COB, Dir, 10% | P - Purchase | $2.50 | +20.0K | 122.5K | +20% | +$50.0K |
| 2026-02-18 | 2026-02-10 | COTY | COTY INC. | Mercier Laurent | CFO | P - Purchase | $2.65 | +5,000 | 500.0K | +1% | +$13.2K | |
| 2026-02-18 | 2026-02-13 | CHGG | CHEGG, INC | ROSENSWEIG DANIEL | Pres, CEO, EXEC COB, Dir | P - Purchase | $0.56 | +100.0K | 7.63M | +1% | +$56.0K | |
| 2026-02-18 | 2026-02-18 | CVRX | CVRx, Inc. | Jain Mudit K. | Dir | P - Purchase | $4.64 | +600 | 5,650 | +12% | +$2,784 | |
| M | 2026-02-18 | 2026-01-21 | LNZA | LanzaTech Global, Inc. | Guardians of New Zealand Superannuation | 10% | P - Purchase | $4.43 | +969.9K | 1.30M | +292% | +$4.30M |
| M | 2026-02-18 | 2026-02-13+ | LXRX | LEXICON PHARMACEUTICALS, INC. | DEBBANE RAYMOND | Dir | P - Purchase | $1.31 | +268.5K | 1.65M | +19% | +$353.1K |
| MI | 2026-02-18 | 2026-02-17 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.77 | +774 | 65.8K | +1% | +$2,144 |
| 2026-02-18 | 2026-02-17 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.77 | +360 | 148.5K | +0.2% | +$997.20 | |
| I | 2026-02-17 | 2026-02-17 | CNVS | Cineverse Corp. | MCGURK CHRISTOPHER J | CEO, COB, Dir | P - Purchase | $2.00 | +75.0K | 178.5K | +72% | +$150.0K |
| 2026-02-17 | 2026-02-17 | CNVS | Cineverse Corp. | Torres Mark | CHRO | P - Purchase | $2.00 | +25.0K | 183.3K | +16% | +$50.0K | |
| MI | 2026-02-17 | 2026-02-12 | VTSI | VirTra, Inc | Brown Jeffrey Dale | Dir | P - Purchase | $4.50 | +3,430 | 1,429 | New | +$15.4K |
| M | 2026-02-17 | 2026-02-12 | VTSI | VirTra, Inc | Brown Jeffrey Dale | Dir | P - Purchase | $4.46 | +3,430 | 57.6K | +6% | +$15.3K |
| 2026-02-17 | 2026-02-17 | CNVS | Cineverse Corp. | Huidor Mark Antonio | Pres Tech, Chief Product Off | P - Purchase | $2.00 | +37.5K | 190.1K | +25% | +$75.0K | |
| D | 2026-02-17 | 2026-02-12 | COCH | Envoy Medical, Inc. | TAYLOR GLEN A | 10% | P - Purchase | $0.4 | +18.75M | 21.70M | +635% | +$7.50M |
| D | 2026-02-17 | 2026-02-12 | COCH | Envoy Medical, Inc. | Potashnick Robert | Interim CFO | P - Purchase | $0.4 | +212.5K | 212.5K | New | +$85.0K |
| D | 2026-02-17 | 2026-02-12 | COCH | Envoy Medical, Inc. | Lucas Brent T. | CEO, Dir | P - Purchase | $0.4 | +62.5K | 297.1K | +27% | +$25.0K |
| 2026-02-17 | 2026-02-12 | ENTX | Entera Bio Ltd. | Rubin Steven D | Dir | P - Purchase | $1.49 | +5,000 | 15.0K | +50% | +$7,450 | |
| 2026-02-17 | 2026-02-17 | CNVS | Cineverse Corp. | LOFFREDO GARY S | CLO, Sec, Sr Advisor | P - Purchase | $2.00 | +30.0K | 200.3K | +18% | +$60.0K | |
| MI | 2026-02-17 | 2026-02-13 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.83 | +774 | 65.7K | +1% | +$2,190 |
| 2026-02-17 | 2026-02-13 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.83 | +360 | 148.1K | +0.2% | +$1,019 | |
| MI | 2026-02-17 | 2026-02-15 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.06 | +1.87M | 29.52M | +7% | +$1.98M |
| 2026-02-17 | 2026-02-17 | CNVS | Cineverse Corp. | Lindsey Mark Wayne | CFO | P - Purchase | $2.00 | +35.0K | 154.2K | +29% | +$70.0K | |
| D | 2026-02-17 | 2026-02-10 | ERNA | Ernexa Therapeutics Inc. | Cherington Charles | 10% | P - Purchase | $0.5 | +4.00M | 6.78M | +144% | +$2.00M |
| 2026-02-17 | 2026-02-17 | DLPN | Dolphin Entertainment, Inc. | O'Dowd William IV | CEO, Dir | P - Purchase | $1.47 | +3,300 | 438.0K | +0.8% | +$4,851 | |
| D | 2026-02-17 | 2026-02-12 | COCH | Envoy Medical, Inc. | Patel Mona Chetan | Dir | P - Purchase | $0.4 | +312.5K | 332.5K | +1,562% | +$125.0K |
| 2026-02-17 | 2026-02-17 | CNVS | Cineverse Corp. | Macias Yolanda | Chief Motion Pictures Off | P - Purchase | $2.00 | +30.0K | 121.8K | +33% | +$60.0K | |
| 2026-02-17 | 2026-02-17 | CNVS | Cineverse Corp. | OPEKA ERICK | CSO, Pres | P - Purchase | $2.00 | +30.0K | 224.1K | +15% | +$60.0K | |
| M | 2026-02-17 | 2025-11-21+ | AVX | AVAX ONE TECHNOLOGY LTD. | KAHN JOLIE | CEO | P - Purchase | $1.66 | +4,000 | 170.6K | +2% | +$6,650 |
| M | 2026-02-17 | 2026-02-17 | IRIX | IRIDEX CORP | Dizon Romeo R | CFO | P - Purchase | $1.34 | +2,200 | 118.7K | +2% | +$2,942 |
| D | 2026-02-17 | 2026-02-12 | COCH | Envoy Medical, Inc. | Kantor Susan | Dir | P - Purchase | $0.4 | +96.2K | 174.0K | +123% | +$38.5K |
| D | 2026-02-17 | 2026-02-12 | COCH | Envoy Medical, Inc. | BRYNELSEN CHARLES | Dir | P - Purchase | $0.4 | +1.00M | 1.05M | +2,000% | +$400.0K |
| M | 2026-02-13 | 2026-02-10+ | RBBN | Ribbon Communications Inc. | McClelland Bruce William | Pres, CEO, Dir | P - Purchase | $2.01 | +37.0K | 1.52M | +3% | +$74.3K |
| 2026-02-13 | 2026-02-12 | ONCY | ONCOLYTICS BIOTECH INC | Brown Deborah Margaret | Dir | P - Purchase | $0.85 | +25.0K | 109.9K | +29% | +$21.2K | |
| 2026-02-13 | 2026-02-13 | TSI | TCW STRATEGIC INCOME FUND INC | McMillan Peter | Dir | P - Purchase | $4.71 | +17.4K | 217.4K | +9% | +$81.9K | |
| M | 2026-02-13 | 2026-02-11+ | NRXS | Neuraxis, INC | Hannasch Brian | 10% | P - Purchase | $4.79 | +80.0K | 1.17M | +7% | +$382.8K |
| 2026-02-13 | 2026-02-12 | ONCY | ONCOLYTICS BIOTECH INC | Look Kirk | CFO | P - Purchase | $0.84 | +12.0K | 287.5K | +4% | +$10.1K | |
| 2026-02-13 | 2026-02-11 | PSEC | PROSPECT CAPITAL CORP | Eliasek M Grier | COO, Dir | P - Purchase | $2.92 | +942.8K | 3.44M | +38% | +$2.75M | |
| 2026-02-13 | 2026-02-12 | ONCY | ONCOLYTICS BIOTECH INC | Andrews Patricia S | Dir | P - Purchase | $0.86 | +35.4K | 78.1K | +83% | +$30.4K | |
| 2026-02-13 | 2026-02-12 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, Dir, 10% | P - Purchase | $0.37 | +388.5K | 8.86M | +5% | +$143.8K | |
| M | 2026-02-13 | 2026-02-11+ | ONCY | ONCOLYTICS BIOTECH INC | Kelly Jared | CEO, Dir | P - Purchase | $0.84 | +35.1K | 109.0K | +47% | +$29.5K |
| MI | 2026-02-13 | 2026-02-11+ | SNES | SenesTech, Inc. | GLENBROOK CAPITAL MANAGEMENT | 10% | P - Purchase | $1.81 | +31.3K | 610.4K | +5% | +$56.6K |
| M | 2026-02-13 | 2026-02-11+ | ONCY | ONCOLYTICS BIOTECH INC | Seizinger Bernd R. | Dir | P - Purchase | $0.838 | +100.0K | 567.0K | +21% | +$83.8K |
| 2026-02-13 | 2026-02-12 | ONCY | ONCOLYTICS BIOTECH INC | Hagerman Allison | VP, Product Development | P - Purchase | $0.83 | +10.0K | 115.1K | +10% | +$8,300 | |
| 2026-02-13 | 2026-02-12 | ONCY | ONCOLYTICS BIOTECH INC | Pisano Wayne | Dir | P - Purchase | $0.84 | +30.0K | 492.4K | +6% | +$25.2K | |
| 2026-02-13 | 2026-02-12 | ONCY | ONCOLYTICS BIOTECH INC | Heineman Thomas Charles | Chief Medical Off | P - Purchase | $0.83 | +12.1K | 282.8K | +4% | +$10.1K | |
| 2026-02-13 | 2026-02-12 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.73 | +360 | 147.7K | +0.2% | +$982.80 | |
| MI | 2026-02-13 | 2026-02-12 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.73 | +774 | 316.9K | +0.2% | +$2,113 |
| 2026-02-13 | 2026-02-11 | ONCY | ONCOLYTICS BIOTECH INC | Aromando Andrew | Chief Business Off | P - Purchase | $0.86 | +29.6K | 55.1K | +116% | +$25.5K | |
| M | 2026-02-12 | 2026-02-11+ | TSI | TCW STRATEGIC INCOME FUND INC | McMillan Peter | Dir | P - Purchase | $4.73 | +190.0K | 200.0K | +1,900% | +$898.8K |
| MI | 2026-02-12 | 2026-02-11 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.65 | +774 | 65.6K | +1% | +$2,051 |
| 2026-02-12 | 2026-02-11 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.65 | +360 | 147.4K | +0.2% | +$954 | |
| D | 2026-02-12 | 2026-02-10 | FIEE | FiEE, Inc. | Wong Man Ching | 10% | P - Purchase | $1.29 | +2.14M | 3.12M | +218% | +$2.76M |
| 2026-02-12 | 2026-02-12 | IRIX | IRIDEX CORP | Dizon Romeo R | CFO | P - Purchase | $1.43 | +1,500 | 117.7K | +1% | +$2,145 | |
| 2026-02-12 | 2026-02-11 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, Dir, 10% | P - Purchase | $0.41 | +291.3K | 8.47M | +4% | +$119.4K | |
| 2026-02-11 | 2026-02-09 | ENTX | Entera Bio Ltd. | Rubin Steven D | Dir | P - Purchase | $1.20 | +10.0K | 10.0K | New | +$12.0K | |
| 2026-02-11 | 2026-02-09 | LAW | CS Disco, Inc. | Offerdahl James | Dir | P - Purchase | $3.99 | +3,000 | 223.7K | +1% | +$12.0K | |
| MI | 2026-02-11 | 2026-02-10 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.71 | +774 | 5,300 | +17% | +$2,098 |
| 2026-02-11 | 2026-02-10 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.71 | +360 | 147.0K | +0.2% | +$975.60 | |
| 2026-02-11 | 2026-02-09 | ENTX | Entera Bio Ltd. | Ellis Sean | Dir | P - Purchase | $1.24 | +18.0K | 178.1K | +11% | +$22.3K | |
| 2026-02-11 | 2026-02-05 | LEE | LEE ENTERPRISES, Inc | Quint Digital Ltd | 10% | P - Purchase | $3.25 | +2.45M | 3.21M | +321% | +$7.97M | |
| 2026-02-11 | 2026-02-10 | ENTX | Entera Bio Ltd. | Taitel Haya | Dir | P - Purchase | $1.48 | +7,500 | 98.5K | +8% | +$11.1K | |
| 2026-02-11 | 2026-02-10 | ENTX | Entera Bio Ltd. | Germano Geno J | Dir | P - Purchase | $1.49 | +20.0K | 20.0K | New | +$29.8K | |
| 2026-02-11 | 2026-02-09 | DLPN | Dolphin Entertainment, Inc. | O'Dowd William IV | CEO, Dir | P - Purchase | $1.64 | +3,000 | 434.7K | +0.7% | +$4,920 | |
| 2026-02-10 | 2026-02-10 | IRIX | IRIDEX CORP | Dizon Romeo R | CFO | P - Purchase | $1.46 | +1,000 | 116.2K | +0.9% | +$1,460 | |
| 2026-02-10 | 2026-02-09 | LSAK | LESAKA TECHNOLOGIES INC | Mazanderani Ali | Executive COB, Dir | P - Purchase | $4.36 | +91.4K | 2.42M | +4% | +$398.6K | |
| 2026-02-10 | 2025-12-18 | RCG | RENN Fund, Inc. | DOYLE PETER | Co-Portfolio Manager | P - Purchase | $2.60 | +300 | 300 | New | +$780 | |
| MI | 2026-02-10 | 2026-02-09 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.68 | +774 | 356.3K | +0.2% | +$2,074 |
| 2026-02-10 | 2026-02-09 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.68 | +360 | 146.7K | +0.2% | +$964.80 | |
| 2026-02-09 | 2026-02-06 | GALT | GALECTIN THERAPEUTICS INC | ELDRED KARY | Dir | P - Purchase | $2.70 | +300 | 65.7K | +0.5% | +$810 | |
| MI | 2026-02-09 | 2026-02-06 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.70 | +774 | 65.3K | +1% | +$2,090 |
| 2026-02-09 | 2026-02-06 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.70 | +360 | 146.3K | +0.2% | +$972.00 | |
| I | 2026-02-09 | 2026-02-06 | COCP | Cocrystal Pharma, Inc. | FROST PHILLIP MD ET AL | Dir, 10% | P - Purchase | $0.95 | +50.0K | 1.89M | +3% | +$47.5K |
| A | 2026-02-06 | 2025-07-03 | CV | CapsoVision, Inc | Tsai Chen Lung | Dir | P - Purchase | $4.17 | +20 | 20 | New | +$83.40 |
| MI | 2026-02-06 | 2026-02-04+ | SNES | SenesTech, Inc. | GLENBROOK CAPITAL MANAGEMENT | 10% | P - Purchase | $1.80 | +8,569 | 602.4K | +1% | +$15.5K |
| MI | 2026-02-06 | 2026-02-05 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.64 | +774 | 355.7K | +0.2% | +$2,043 |
| 2026-02-06 | 2026-02-05 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.64 | +360 | 145.9K | +0.2% | +$950.40 | |
| 2026-02-05 | 2025-12-18 | CFND | C1 Fund Inc. | Singer Jeffrey H. | Dir | P - Purchase | $4.89 | +2,000 | 2,000 | New | +$9,780 | |
| MI | 2026-02-05 | 2026-02-04 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.73 | +774 | 11.3K | +7% | +$2,113 |
| 2026-02-05 | 2026-02-04 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.73 | +360 | 145.6K | +0.2% | +$982.80 | |
| I | 2026-02-04 | 2026-02-02 | LXRX | LEXICON PHARMACEUTICALS, INC. | Artal Group S.A. | Dir, 10% | P - Purchase | $1.30 | +1.54M | 1.54M | New | +$2.00M |
| I | 2026-02-04 | 2026-02-02 | ALXO | ALX ONCOLOGY HOLDINGS INC | GOODMAN COREY S | Dir, 10% | P - Purchase | $1.57 | +3.18M | 8.45M | +60% | +$5.00M |
| M | 2026-02-04 | 2026-02-02+ | EMPD | Empery Digital Inc. | ATG Capital Opportunities Fund LP | 10% | P - Purchase | $4.68 | +691.1K | 4.50M | +18% | +$3.23M |
| 2026-02-04 | 2026-02-02 | FEAM | 5E Advanced Materials, Inc. | BEP Special Situations IV LLC | Dir, 10% | P - Purchase | $2.00 | +4.00M | 12.13M | +49% | +$8.00M | |
| D | 2026-02-04 | 2025-12-05 | BOLT | Bolt Biotherapeutics, Inc. | Quinn William P. | Pres, CEO, CFO, Dir | P - Purchase | $4.61 | +125 | 2,313 | +6% | +$576.25 |
| I | 2026-02-04 | 2026-02-04 | STEX | Streamex Corp. | GIUSTRA FRANK | 10% | P - Purchase | $3.17 | +100.0K | 1.28M | +8% | +$317.0K |
| D | 2026-02-04 | 2025-12-05 | BOLT | Bolt Biotherapeutics, Inc. | Nemec Sarah | Senior VP, Fin, PAO | P - Purchase | $4.61 | +125 | 1,415 | +10% | +$576.25 |
| MI | 2026-02-04 | 2026-02-03 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.74 | +774 | 355.1K | +0.2% | +$2,121 |
| 2026-02-04 | 2026-02-03 | RCG | RENN Fund, Inc. | STAHL MURRAY | Pres, Co-Portfolio Manager, 10% | P - Purchase | $2.74 | +360 | 145.2K | +0.2% | +$986.40 |
Purchase Sale Sale after option exercise All abbreviations